`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______
`
`
`
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioner,
`
`
`
`v.
`
`
`
`NOVARTIS A.G.,
`Patent Owner.
`
`_______
`
`U.S. Patent No. 9,187,405
`Inter Partes Review No. Unassigned
`
`
`
`PETITIONER’S POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`Patent No. 9,187,405
`
`Petitioner Argentum Pharmaceuticals LLC hereby appoints the Practitioners
`
`
`
`associated with PTO Customer Number 23911 (Crowell & Moring LLP) and Tyler
`
`C. Liu (Reg. 72,126, Argentum Pharmaceuticals LLC) as its attorneys to transact
`
`all business in the U.S. Patent & Trademark Office in connection with any inter
`
`partes review of the captioned patent(s), including the appointment of lead and
`
`backup counsel.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`For:
`
`
`
`Argentum Pharmaceuticals LLC
`
`Name:
`
`Jeffrey R. Gardner, B.S., MBA
`
`Title:
`
`Chief Executive Officer
`
`
`
`Signature: __________________________
`
`Date:
`
`__________________________
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`02 JUNE, 2017
`
`